From the experts in cyber skin-cancer treatment


  • Skin cancer is the leading form of cancer in the U.S.
  • The incidence of skin cancer is continuing to increase with the aging population
  • 4.55 million cases are estimated in 2016 in the U.S. This number is expected to continue to grow as the population ages
  • An estimated 18 million Keloid patients in the U.S. are looking for a cure to their condition, which often can be painful and debilitating
  • Office-based SRT technology with imaging capability is new to the Dermatology market
  • For the first time, Dermatologists can now determine cancerous lesion breadth and depth using ultrasound linked to the treating device
  • Today less than 1% of Dermatology practices have SRT capability within their practices
  • The number of practices seeking SRT is expected to increase dramatically in the next few years as patients demand alternative curative treatments to Mohs surgery


The technology to
move you forward.

No capital required
Risk-free solution
Turnkey implementation
Leverages time for Dermatologists and Mohs surgeons
All the rewards.
None of the risks.

The Result

95%+ skin cancer cure rates.
100% support from SkinCure Oncology.

Excellent cure
rates that
rival surgery

No anesthesia,
cutting, bleeding,
stitching or pain

Superior cosmesis,
no unsightly scarring

Short treatment sessions

No downtime or lifestyle restrictions

No need for
post-treatment reconstructive surgeries

What are patients and
physicians saying about SRT?

  • "Joining the SkinCure Oncology team has really opened my eyes to the numerous ways technology can help optimize patient satisfaction and outcomes. As a Mohs surgeon, I know firsthand that many skin cancer patients would prefer a non-invasive alternative. The support staff that SkinCure Oncology provides has been a pleasure to work with, and has improved access to care for my patients."

    Dr. Ladd Jr.

  • "The SkinCure Oncology team has exceeded my expectations in every way. Since adding the SRT capabilities, we’ve been able to expand our treatment protocols to better serve our current patients as well as acquire new ones."

    Dr. Brown

  • "We’re an extremely patient-focused group. Recommending the optimal solution for our patients' dermatology needs is our number one priority. Based on our initial interactions with SkinCure, as well as feedback from our patients, we’re expanding the SRT program to additional locations."

    Dr. Desai